LOMILIN

Medigene Ag

Application Filed: 2006-04-17

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	78862547
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Linda M. Byrne
Attorney Name	Linda M. Byrne, Robert Crawford, Eric Curtin
Attorney Docket Number	MEGE.101TM
Law Office Assigned	M60
Employee Name	FRENCH, CURTIS W

Timeline

2006-04-17	Application Filed
2006-11-28	Published for Opposition
2008-02-01	Location: INTENT TO USE SECTION
2008-08-21	Abandon
2008-08-21	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	MEDIGENE AG
Address	Lochhamer Strasse 11 Martinsried DE
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Linda M. Byrne
Crawford Maunu PLLC
1150 Northland Drive, Suite 100
St. Paul MN 55120

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical products for topical, intra-vaginal and/or intra-anal application, namely, pharmaceutical preparations for use in treating the skin diseases of warts, verruca vulgaris, verruca plantaris, verruca plana, flat condylomata, mosaic-type warts, butcher's warts, anogenital warts, condylomata accuminata, hyperplasia of the epidermis, recalcitrant cutaneous warts, herpes infection, genital and anal herpes infection, shingles, Molluscum contagiosum, mycosis, mycosis fungoides, tinea, tinea pedis, pigmentation disorders, hyperpigmentation, hypopigmentation, vitiligo, melasma, atypical/displastic/melanocytic nevi, sun-damaged skin, removal of tattoos, psoriasis, neurodermitis, dermatitis, atopic dermatitis, cutaneous atopy, eczema, lichen planus, cutaneous lupus erythematosus, skin ulcers, rosacea, precancerous and cancerous lesions, increased proliferation of skin cells, actinic keratosis, actinic cheilitis, keloids, lentigo, hemangioma, Epidermodysplasia verruciformis, Bowen's disease, Bowenoid papulosis, basal cell carcinoma, intraepithelial squamous cell carcinoma, melanoma, and other skin cancers, neoplasias, cervical dysplasia, cervical intraepithelial neoplasias, anal intraepithelial neoplasias, vulvar intraepithelial neoplasia, penile cancer, vulvovaginal cancer, anal carcinoma, cervical carcinoma, cutaneous T-cell lymphoma, alopecia, vulvodynia, keloid and hypertrophic scars, post surgical excision on scar cosmesis, hyperkeratosis, seborrhea, Darier's disease, porokeratosis of mibelli, ichthyosis, xerosis, dartroud disthesis, acne, nasal papilloma, oral papilloma, focal epithelial hyperplasia, laryngeal papilloma, recurrent respiratory papillomatosis and conjunctival papilloma

Type Code

Type

GS0051

Pharmaceutical products for topical, intra-vaginal and/or intra-anal application, namely, pharmaceutical preparations for use in treating the skin diseases of warts, verruca vulgaris, verruca plantaris, verruca plana, flat condylomata, mosaic-type warts, butcher's warts, anogenital warts, condylomata accuminata, hyperplasia of the epidermis, recalcitrant cutaneous warts, herpes infection, genital and anal herpes infection, shingles, Molluscum contagiosum, mycosis, mycosis fungoides, tinea, tinea pedis, pigmentation disorders, hyperpigmentation, hypopigmentation, vitiligo, melasma, atypical/displastic/melanocytic nevi, sun-damaged skin, removal of tattoos, psoriasis, neurodermitis, dermatitis, atopic dermatitis, cutaneous atopy, eczema, lichen planus, cutaneous lupus erythematosus, skin ulcers, rosacea, precancerous and cancerous lesions, increased proliferation of skin cells, actinic keratosis, actinic cheilitis, keloids, lentigo, hemangioma, Epidermodysplasia verruciformis, Bowen's disease, Bowenoid papulosis, basal cell carcinoma, intraepithelial squamous cell carcinoma, melanoma, and other skin cancers, neoplasias, cervical dysplasia, cervical intraepithelial neoplasias, anal intraepithelial neoplasias, vulvar intraepithelial neoplasia, penile cancer, vulvovaginal cancer, anal carcinoma, cervical carcinoma, cutaneous T-cell lymphoma, alopecia, vulvodynia, keloid and hypertrophic scars, post surgical excision on scar cosmesis, hyperkeratosis, seborrhea, Darier's disease, porokeratosis of mibelli, ichthyosis, xerosis, dartroud disthesis, acne, nasal papilloma, oral papilloma, focal epithelial hyperplasia, laryngeal papilloma, recurrent respiratory papillomatosis and conjunctival papilloma

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2006-04-21	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2006-09-22	2 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2006-09-22	3 CNSA P:
ASSIGNED TO LIE	2006-09-29	4 ALIE A:Allowance for Publication
ASSIGNED TO LIE	2006-10-05	5 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2006-10-06	6 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2006-11-08	7 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2006-11-28	8 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT	2007-02-20	9 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2007-05-21	10 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2007-05-21	11 EXT1 S:
EXTENSION 1 GRANTED	2007-05-21	12 EX1G S:
ASSIGNED TO EXAMINER	2007-12-03	13 DOCK D:Assigned to Examiner
TEAS EXTENSION RECEIVED	2008-01-15	14 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2008-01-15	15 EXT2 S:
EXTENSION 2 GRANTED	2008-02-04	16 EX2G S:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2008-03-03	17 TCCA I:Incoming Correspondence
ABANDONMENT - NO USE STATEMENT FILED	2008-10-22	18 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2008-10-22	19 MAB6 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.